New Delhi, July 22 (IANS) The UK subsidiary of generic drug manufacturer Ranbaxy Laboratory has been acquitted in a fraud case against it, the pharma major said here Tuesday. In a regulatory statement, Ranbaxy said a case filed by the UK Serious Fraud Office (SFO) against its subsidiary Ranbaxy UK was quashed by the English Crown Court.

The statement said the court also declined an application by SFO seeking permission to appeal to the English Court of Appeal, even though SFO had the right to appeal to the court directly, Ranbaxy said in the release.

The statement said Ranbaxy was a responsible company committed to providing high quality generic medicines at affordable prices to patients around the world.

Ranbaxy UK and five other companies were accused of price fixing to defraud the UK health service.